EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Activity
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

53 hedge funds and large institutions have $118M invested in Eiger BioPharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+3
Holders Change %
+6%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
17
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
6CM
683 Capital Management
New York
$7.58M
2
EIM
Essex Investment Management
Massachusetts
$619K
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
$600K
4
Renaissance Technologies
Renaissance Technologies
New York
$3.35M
5
AG
Algert Global
California
$815K

Top Sellers

1
GC
GMT Capital
Georgia
$0
2
HCM
Highbridge Capital Management
New York
$0
3
PM
Prosight Management
Texas
$4.1M
4
UC
Unterberg Capital
New York
$0
5
Millennium Management
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PCTC
51
Perkins Coie Trust Company
Washington
$2K – – –
GC
52
GMT Capital
Georgia
– -$3.46M -9,451 Closed
HCM
53
Highbridge Capital Management
New York
– -$1.72M -4,702 Closed
UC
54
Unterberg Capital
New York
– -$976K -2,667 Closed
Millennium Management
55
Millennium Management
New York
– -$871K -2,379 Closed
EAM
56
Eventide Asset Management
Massachusetts
– -$439K -1,200 Closed
BFM
57
Boothbay Fund Management
New York
– -$243K -665 Closed
HIM
58
Hillsdale Investment Management
Ontario, Canada
– -$76K -207 Closed
Bank of Montreal
59
Bank of Montreal
Ontario, Canada
– -$4K -10 Closed
1 2
3